Golden Biotechnology Corporation (TPEX:4132)
Taiwan · Delayed Price · Currency is TWD 10.85
-0.55 (-4.82%)
Aug 1, 2025, 1:38 PM CST
Golden Biotechnology Company Description
Golden Biotechnology Corporation operates as a drug discovery and healthy food supplement manufacturing company in Taiwan, the United States, Japan, China, Korea, and Singapore.
Its products include Liverty that is used for liver health support and fatigue; Rasle, an auto-immune adjuvant therapy; ZSAINO, a nourishment product for recovery from illness and for health improvement; and UMOOZE, a herbal formula for optimal health in males.
The company also provides Antroquinonol, an anticancer molecule for the treatment of pancreatic cancer, acute myeloid leukemia, and hepatocellular carcinoma, as well as hypercholesterolemia and hyperlipidemia.
The company was founded in 2002 and is headquartered in New Taipei City, Taiwan.
Golden Biotechnology Corporation
| Country | Taiwan |
| Founded | 2002 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| Employees | 122 |
| CEO | Li Yu Wu |
Contact Details
Address: No. 27-6, Zhongzheng E. Road New Taipei City, 251 Taiwan | |
| Phone | 886 2 2808 6006 |
| Website | goldenbiotech.com |
Stock Details
| Ticker Symbol | 4132 |
| Exchange | Taipei Exchange |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | TWD |
| ISIN Number | TW0004132006 |
| SIC Code | 2836 |
Key Executives
| Name | Position |
|---|---|
| Li Yu Wu | President and Director |
| Zeng Ganmu | Accounting Supervisor |
| Jun Hua Lian | Treasurer |